ProfileGDS5678 / 1447110_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 53% 52% 52% 49% 52% 52% 52% 52% 50% 51% 52% 51% 56% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3336853
GSM967853U87-EV human glioblastoma xenograft - Control 23.2513352
GSM967854U87-EV human glioblastoma xenograft - Control 33.2589152
GSM967855U87-EV human glioblastoma xenograft - Control 43.1162449
GSM967856U87-EV human glioblastoma xenograft - Control 53.2342452
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3552252
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3429552
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2452752
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1898750
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2143851
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2531552
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1857651
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4105456
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2541452